Narita Yoshinori, Wakita Daiko, Ohkur Takayuki, Chamoto Kenji, Nishimura Takashi
Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Biomed Res. 2009 Feb;30(1):7-15. doi: 10.2220/biomedres.30.7.
Evaluation of immunosuppressive tumor-escape mechanisms in tumor-bearing hosts is of great importance for the development of an efficient tumor immunotherapy. We document here the functional characteristics of CD11b(+)Gr-1(+) immature myeloid cells (ImC), which increase abnormally in tumor-bearing mice. Although it has been reported that ImC exhibit a strong immunosuppressive activity against T cell responses, we demonstrate that ImC derived from tumor-bearing mouse spleens (TB-SPL) did not exhibit a strong inhibitory activity against CTL generation in MLR. However, ImC isolated from TB-SPL and induced to differentiate into CD11b(+)Gr-1(+)F4/80(+) suppressor macrophages (MPhi) under the influence of tumor-derived factors were immunosuppressive. Furthermore, we also demonstrate that ImC isolated from TB-SPL had a capability of differentiating into immunostimulatory dendritic cells (DC1) supportive of the generation of IFN-gamma producing CTL if the ImC were cultured with Th1 cytokines plus GM-CSF and IL-3. Thus, our findings indicate that tumor bearing mouse-derived CD11b(+)Gr-1(+) ImC are not committed to development into immunosuppressor cells but have dual differentiation ability into both immunosuppressive myeloid cells and immunostimulatory DC1.
评估荷瘤宿主中免疫抑制性肿瘤逃逸机制对于开发有效的肿瘤免疫疗法至关重要。我们在此记录了CD11b(+)Gr-1(+)未成熟髓样细胞(ImC)的功能特性,这种细胞在荷瘤小鼠中异常增加。尽管已有报道称ImC对T细胞反应表现出强大的免疫抑制活性,但我们证明,源自荷瘤小鼠脾脏(TB-SPL)的ImC在混合淋巴细胞反应(MLR)中对CTL生成并未表现出强大的抑制活性。然而,在肿瘤衍生因子的影响下,从TB-SPL分离并诱导分化为CD11b(+)Gr-1(+)F4/80(+)抑制性巨噬细胞(MPhi)的ImC具有免疫抑制作用。此外,我们还证明,如果将从TB-SPL分离的ImC与Th1细胞因子加GM-CSF和IL-3一起培养,它们具有分化为支持产生IFN-γ的CTL生成的免疫刺激性树突状细胞(DC1)的能力。因此,我们的研究结果表明,荷瘤小鼠来源的CD11b(+)Gr-1(+)ImC并非注定要发育为免疫抑制细胞,而是具有向免疫抑制性髓样细胞和免疫刺激性DC1双向分化的能力。